Bupivacaine vs Oxybuprocaine Topical Anesthesia in IVI
Launched by RESEARCH INSTITUTE OF OPHTHALMOLOGY, EGYPT · Sep 25, 2021
Trial Information
Current as of June 04, 2025
Completed
Keywords
ClinConnect Summary
In preparation zone, we will cannulate the patients, connect them to the pulse oximetry and we will start providing appropriate surface anaesthesia for an adequate period of time before the patient administration of the injection, by applying the anaesthetic agents, 3 times with 5 minutes interval, for 15 minutes and then waitng the injection
All patients are informed that they are going to receive topical anaesthetic agent before the IVI.
pain is monitored during the injection by using the 11 points verbal numerical pain scaling as zero is for no pain and 10 is for severe unbearable pain.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All patients between 30 to 70 years
- Exclusion Criteria:
- • uncooperative patients
About Research Institute Of Ophthalmology, Egypt
The Research Institute of Ophthalmology in Egypt is a leading clinical research organization dedicated to advancing the field of ophthalmology through innovative research and development. With a commitment to improving ocular health, the institute conducts rigorous clinical trials aimed at evaluating new treatments, therapies, and technologies for various eye conditions. Leveraging a team of experienced researchers, state-of-the-art facilities, and a collaborative approach, the institute plays a vital role in translating scientific discoveries into effective clinical applications, ultimately enhancing patient care and outcomes in ophthalmic medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Giza, Haram, Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials